Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accendra HealthSTU:6OM -0.72%59 Buyback Yield % is 3.62 as of Jul. 24, 2026, which is 125% above its 10-year median of 1.61. GuruFocus rates STU:6OM with a GF Score™ of 59/100 and a GF Value™ of €4.77. The stock has 7 warning signs investors should review. Among 40 Medical Distribution companies, Accendra Health ranks better than 80% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Accendra Health's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:6OM vs FOCL, YI, COSM: Buyback Yield % Comparison
For the Medical Distribution subindustry, Accendra Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Accendra Health's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (STU:6OM) has a Buyback Yield % of 3.62 as of Jul. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Accendra Health and its competitors. This is 125% above median its historical median of 1.61. According to the industry distribution chart, Accendra Health ranks #8 out of 40 companies in the Medical Distribution industry, placing it in the top 20%.
Is Accendra Health's Buyback Yield % too high?
Accendra Health's current Buyback Yield % of 3.62 is 125% above median its 10-year median of 1.61. Based on the distribution chart, Accendra Health ranks #8 out of 40 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Buyback Yield % compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #8 out of 40 companies for Buyback Yield %. This places Accendra Health in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
A good Buyback Yield % depends on the Medical Distribution industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Accendra Health and its competitors. Accendra Health's current Buyback Yield % is 3.62, which is 125% above median its own 10-year median of 1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Accendra Health (STU:6OM) has a current Buyback Yield % of 3.62. The stock's GF Value™ is €4.77, compared to a current price of €2.74 — trading 42.6% below its estimated fair value. The current Buyback Yield % is 3.62, which is 125% above median its 10-year median of 1.61. Accendra Health's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Accendra Health (STU:6OM), the current Buyback Yield % is 3.62 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (STU:6OM) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of €2.74 is trading 42.6% below its estimated GF Value™ of €4.77.
Key valuation signals for STU:6OM:
Buyback Yield %: 3.62 (125% above median its 10-year median of 1.61)
GF Value™: €4.77 vs. price of €2.74 (42.6% below fair value)
No single metric tells the full story. See the STU:6OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
59GF Score
Get the complete analysis for STU:6OM
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:6OM has been successfully added to your 
